|
|
One Riverfront Place Newport, KY 41071-4563 USA phone:859-371-6383 fax:859-371-6391
|
|
| Symbol |
Private |
| Founded |
2001 |
| Employees |
|
|
|
| www.xanodyne.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Products in the therapeutic areas of women's health and pain management, |
 |
| Management |
| Stephen A. Stamp, Chief Financial Officer and Executive Vice President, Business Development; Gary A. Shangold, MD, Chief Medical Officer; Daniel W. Docherty, Vice President, Marketing; Timothy R. Arendt, Vice President, Sales; Thomas P. Jennings, Esq, General Counsel, Vice President, Legal Affairs and Corporate Secretary; Kevin T. Anderson, Esq, Chief Compliance Officer and Vice President, Human Resources
|
| |
|
|
| |
|
| Keywords |
| women's health, women's, womenshealth, women's health, pain management, prenatal vitamins, hycet, Oramorph |
|
|
|
| Description |
|
Xanodyne Pharmaceuticals, Inc., is focusing on innovative products in the therapeutic areas of women's health and pain management, |
 |
| Products / Services |
The company markets a line of prenatal vitamins appropriate for women who are planning and preparing for pregnancy as well as for women who are in their early, middle, and late stages of pregnancy. Xanodyne also markets a broad line of products for pain management, including hycet the Darvon/Darvocet family of products, Oramorph SR, and others. In addition, Xanodyne markets the leading prescription brand Amicar, a hematology product, as well as DexAlone - an over the counter brand cough product.
|
 |
 |
|
|
|
|
|
|